PRE-IVF TREATMENT WITH A GNRH ANTAGONIST IN WOMEN WITH ENDOMETRIOSIS (PREGNANT): STUDY PROTOCOL FOR A PROSPECTIVE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
Women diagnosed with endometriosis-associated infertility are often successfully treated with IVF. The PREGnant study utilizes an oral GnRH antagonist to treat endometriosis prior to IVF start; the efficacy of the treatment will be assessed using live birth rates. This publication further explains the study protocol.